Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 10/20 | 0.57 |
| ▸ | HTR2C | P28335 | 8/20 | 0.57 |
| ▸ | MAOA | P21397 | 7/20 | 0.57 |
| ▸ | KDM1A | O60341 | 5/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.57 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | HTR1A | P08908 | 1/20 | 0.57 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.57 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.57 |
| ▸ | DRD3 | P35462 | 1/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.57 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2768026 | 1.00 | MAOB (0.57) | MAOBHTR2CMAOAKDM1ACYP2C19 | |
| SCHEMBL2769401 | 1.00 | MAOB (0.57) | MAOBHTR2CMAOAKDM1ACYP2C19 | |
| Ammonia Solution, Strong SCHEMBL11529212 | 0.97 | MAOB (0.55) | MAOBHTR2CMAOAKDM1ACYP2C19 | |
| Bicarbonate SCHEMBL7575978 | 0.89 | HDAC4 (0.50) | MAOBHTR2CMAOAKDM1ACYP2C19 | |
| SCHEMBL11904658 | 0.88 | MEN1 (0.65) | MAOBHTR2CMAOAKDM1ACYP2C19 | |
| SCHEMBL415662 | 0.88 | MEN1 (0.65) | MAOBHTR2CMAOAKDM1ACYP2C19 | |
| SCHEMBL31596808 | 0.87 | KDM1A (0.61) | MAOBHTR2CMAOAKDM1ACYP2C19 | |
| SCHEMBL9145559 | 0.83 | SLC18A3 (0.50) | MAOBHTR2CMAOAKDM1ACYP2C19 | |
| SCHEMBL10914783 | 0.83 | MAOB (0.48) | MAOBHTR2CMAOAKDM1ACYP2C19 | |
| SCHEMBL20473102 | 0.83 | MAOB (0.48) | MAOBHTR2CMAOAKDM1ACYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078233-A1 | ENZYMES, MICRO-ORGANISMS AND USES THEREOF, AND A METHOD OF DEGRADING HYDROCARBON CHAINS | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY (FI) | 2026-03-19 | — | — | US | claimed |
| EP-4569018-A1 | ENZYMES, MICRO-ORGANISMS AND USES THEREOF, AND A METHOD OF DEGRADING HYDROCARBON CHAINS | Teknologian Tutkimuskeskus VTT OY (FI) | 2025-06-18 | — | — | EP | claimed |
| WO-2024033572-A1 | ENZYMES, MICRO-ORGANISMS AND USES THEREOF, AND A METHOD OF DEGRADING HYDROCARBON CHAINS | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY (FI) | 2024-02-15 | — | — | WO | claimed |
| US-11224241-B2 | Methods and compositions for affecting the flavor and aroma profile of consumables | IMPOSSIBLE FOODS INC. (US) | 2022-01-18 | — | — | US | claimed |
| US-11219232-B2 | Methods and compositions for affecting the flavor and aroma profile of consumables | IMPOSSIBLE FOODS INC. (US) | 2022-01-11 | — | — | US | claimed |
| US-10327464-B2 | Methods and compositions for affecting the flavor and aroma profile of consumables | IMPOSSIBLE FOODS INC. (US) | 2019-06-25 | — | — | US | claimed |
| US-10314325-B2 | Methods and compositions for affecting the flavor and aroma profile of consumables | IMPOSSIBLE FOODS INC. (US) | 2019-06-11 | — | — | US | claimed |
| EP-0031708-B1 | CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES THEREFOR | ICI PHARMA (FR) | 1984-06-13 | — | — | EP | claimed |
| EP-0075434-A2 | Cephalosporins, their preparation and their pharmaceutical compositions | ICI PHARMA (FR) | 1983-03-30 | — | — | EP | claimed |
| EP-0071370-A2 | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them | ICI PHARMA (FR) | 1983-02-09 | — | — | EP | claimed |
| EP-0031708-A2 | Cephalosporin derivatives, processes for their manufacture, pharmaceutical compositions containing them and intermediates therefor | ICI PHARMA (FR) | 1981-07-08 | — | — | EP | claimed |
| US-20260078233-A1 | ENZYMES, MICRO-ORGANISMS AND USES THEREOF, AND A METHOD OF DEGRADING HYDROCARBON CHAINS | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY (FI) | 2026-03-19 | — | — | US | disclosed |
| EP-4569018-A1 | ENZYMES, MICRO-ORGANISMS AND USES THEREOF, AND A METHOD OF DEGRADING HYDROCARBON CHAINS | Teknologian Tutkimuskeskus VTT OY (FI) | 2025-06-18 | — | — | EP | disclosed |
| EP-2943072-B2 | METHODS FOR AFFECTING THE FLAVOUR AND AROMA PROFILE OF CONSUMABLES | IMPOSSIBLE FOODS INC (US) | 2025-04-30 | — | — | EP | disclosed |
| CN-119889726-A | Semen quality prediction method and system based on random forest | 深圳市疾病预防控制中心(深圳市卫生监督局、深圳市卫生检验中心、深圳市预防医学研究所) | 2025-04-25 | — | — | CN | disclosed |
| US-4463173-A | ANTIBIOTIC, BACTERICIDE | ICI PHARMA (FR) | 1984-07-31 | — | — | US | disclosed |
| EP-0031708-B1 | CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES THEREFOR | ICI PHARMA (FR) | 1984-06-13 | — | — | EP | disclosed |
| EP-0075434-A2 | Cephalosporins, their preparation and their pharmaceutical compositions | ICI PHARMA (FR) | 1983-03-30 | — | — | EP | disclosed |
| EP-0071370-A2 | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them | ICI PHARMA (FR) | 1983-02-09 | — | — | EP | disclosed |
| EP-0031708-A2 | Cephalosporin derivatives, processes for their manufacture, pharmaceutical compositions containing them and intermediates therefor | ICI PHARMA (FR) | 1981-07-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078233-A1 | ENZYMES, MICRO-ORGANISMS AND USES THEREOF, AND A METHOD OF DEGRADING HYDROCARBON CHAINS | PREP, CPSF1, CPSF7 | MAOB 1509/4885HTR2C 3647/4885MAOA 1290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.